Management of Suspected Melatonin Overdose with Suicidal Ideation

Psychiatric Emergency Management

The American Academy of Pediatrics recommends placing patients in hospital attire after a personal belongings search to remove access to potential means of self-harm, assigning continuous observation in a room without easy access to medical equipment, and interviewing patients and collateral sources separately to obtain an accurate history 2
Patients expressing a desire to die require immediate evaluation for psychiatric hospitalization if they meet high-risk criteria, including persistence in endorsing desire to die, continued agitation or severe hopelessness, inability to participate in safety planning discussions, inadequate support system, or history of high-lethality suicide attempts 1
A comprehensive suicide risk evaluation should assess multiple risk domains systematically, including self-directed behaviors, current suicidal thoughts, psychiatric conditions, social determinants, access to lethal means, and additional risk factors such as male gender, comorbid substance abuse, and high levels of anger or impulsivity 1, 2

The FDA warns of exacerbation of depression and suicidal ideation in primarily depressed patients taking ramelteon, a melatonin receptor agonist, and recommends heightened vigilance for suicide risk in patients with mental health comorbidities prescribed melatonin 3, 4

A comprehensive safety plan is mandatory before discharge from the emergency department and should include identification of specific warning signs and triggers for recurrent suicidal ideation, concrete coping strategies, a list of responsible social supports, professional support contacts, and clear instructions on how and when to reaccess emergency services 1
Counseling on lethal means restriction is fundamental to discharge planning and should include specific recommendations for securing potential means of self-harm, such as locking medications and removing firearms from the home 1
The American Academy of Child and Adolescent Psychiatry recommends avoiding prescribing medications that reduce self-control, such as benzodiazepines and phenobarbital, in suicidal patients, and instead using SSRIs as preferred antidepressants due to their low lethality in overdose 5

The Annals of Internal Medicine recommends not relying exclusively on any single screening tool to determine suicide risk, but instead using multiple assessment methods, including clinical interview and collateral information 6
The American Academy of Pediatrics recommends not performing routine laboratory testing or brain imaging in psychiatrically stable patients with normal vital signs and non-contributory history and physical examination, as these tests are low yield and costly 2
The American College of Physicians recommends not underestimating the seriousness of melatonin overdose as a suicide gesture, and instead requiring full evaluation regardless of the low medical toxicity 1